Sonnet BioTherapeutics Holdings Inc logo

Sonnet BioTherapeutics Holdings Inc

FRA:H3D (USA)   Ordinary Shares
€ 5.41 (0%) Feb 14
At Loss
Market Cap:
€ 4.59M ($ 4.73M)
Enterprise V:
€ 2.65M ($ 2.74M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Sonnet BioTherapeutics Holdings Inc Valuation Measures